A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

Clinical trial NCT06659341 · RECRUITING

Trial details

NCT number: NCT06659341
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Harboring KRAS G12C Mutation

Start date: 2024-11-08
Primary completion: 2027-01-11
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.